Publications
Found 7 results
Filters: Author is J.G. Wang [Clear All Filters]
“Analysis of an “off-ladder” allele at the Penta D short tandem repeat locus”, vol. 14, pp. 15096-15101, 2015.
, “Polymorphisms of PRLR and FOLR1 genes and association with milk production traits in goats”, vol. 13, pp. 2555-2562, 2014.
, , “Cloning, sequencing, and polymorphisms of the Wistar-Imamichi rat growth hormone gene using PCR-SSCP”, vol. 12, pp. 6203-6211, 2013.
, “Molecular cloning and characterization of KISS1 promoter and effect of KISS1 gene mutations on litter size in the goat”, vol. 12, pp. 4308-4316, 2013.
, “A new approach for cloning hLIF cDNA from genomic DNA isolated from the oral mucous membrane”, vol. 10, pp. 3455-3462, 2011.
,
An X, Lu J, Huang JD, Zhang B, et al. (2007). Rapid assembly of multiple-exon cDNA directly from genomic DNA. PLoS One 2: e1179.
http://dx.doi.org/10.1371/journal.pone.0001179
PMid:18000550 PMCid:2048664
Bertrand E, Pictet R and Grange T (1994). Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 22: 293-300.
http://dx.doi.org/10.1093/nar/22.3.293
PMid:7510389 PMCid:523579
Bustin SA and Nolan T (2004). Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J. Biomol. Tech. 15: 155-166.
PMid:15331581 PMCid:2291693
Eikmans M, Baelde HJ, De HE and Bruijn JA (2000). Processing renal biopsies for diagnostic mRNA quantification: improvement of RNA extraction and storage conditions. J. Am. Soc. Nephrol. 11: 868-873.
PMid:10770964
Hoover DM and Lubkowski J (2002). DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 30: e43.
http://dx.doi.org/10.1093/nar/30.10.e43
PMid:12000848 PMCid:115297
Lebedenko EN, Birikh KR, Plutalov OV and Berlin Y (1991). Method of artificial DNA splicing by directed ligation (SDL). Nucleic Acids Res. 19: 6757-6761.
http://dx.doi.org/10.1093/nar/19.24.6757
PMid:1662363 PMCid:329306
Li XX, Zheng F, Jiao YL, Guo G, et al. (2008). An alternative approach to synthesize cDNA bypassing traditional reverse transcription. Mol. Biotechnol. 39: 201-206.
http://dx.doi.org/10.1007/s12033-008-9035-x
PMid:18228164
Stemmer WP (1994a). DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. U. S. A. 91: 10747-10751.
http://dx.doi.org/10.1073/pnas.91.22.10747
PMid:7938023 PMCid:45099
Stemmer WP (1994b). Rapid evolution of a protein in vitro by DNA shuffling. Nature 370: 389-391.
http://dx.doi.org/10.1038/370389a0
PMid:8047147
Stemmer WP, Crameri A, Ha KD, Brennan TM, et al. (1995). Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 164: 49-53.
http://dx.doi.org/10.1016/0378-1119(95)00511-4
Vandenbroeck K, Dijkmans R, van Aerschot A and Billiau A (1991). Engineering by PCR-based exon amplification of the genomic porcine interferon-gamma DNA for expression in Escherichia coli. Biochem. Biophys. Res. Commun. 180: 1408-1415.
http://dx.doi.org/10.1016/S0006-291X(05)81353-1
Xiong AS, Yao QH, Peng RH, Duan H, et al. (2006). PCR-based accurate synthesis of long DNA sequences. Nat. Protoc. 1: 791-797.
http://dx.doi.org/10.1038/nprot.2006.103
PMid:17406309
Young L and Dong Q (2004). Two-step total gene synthesis method. Nucleic Acids Res. 32: e59.
http://dx.doi.org/10.1093/nar/gnh058
PMid:15087491 PMCid:407838
Zhu X, Chen J, Zhang X, An X, et al. (2007). Correction of a mutation in a synthetic gene by DREAM technique, a site-directed mutagenesis. China Biotechnol. 27: 86-92.
“STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer”, vol. 10, pp. 1856-1865, 2011.
, Abdulghani J, Gu L, Dagvadorj A, Lutz J, et al. (2008). Stat3 promotes metastatic progression of prostate cancer. Am. J. Pathol. 172: 1717-1728.
http://dx.doi.org/10.2353/ajpath.2008.071054
PMid:18483213 PMCid:2408430
Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
http://dx.doi.org/10.1093/bioinformatics/bth457
PMid:15297300
Barrett JC, Hansoul S, Nicolae DL, Cho JH, et al. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40: 955-962.
http://dx.doi.org/10.1038/ng.175
PMid:18587394 PMCid:2574810
Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, et al. (2009). gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15: 91-102.
http://dx.doi.org/10.1016/j.ccr.2009.01.002
PMid:19185844
Bowman T, Garcia R, Turkson J and Jove R (2000). STATs in oncogenesis. Oncogene 19: 2474-2488.
http://dx.doi.org/10.1038/sj.onc.1203527
PMid:10851046
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, et al. (1999). Stat3 as an oncogene. Cell 98: 295-303.
http://dx.doi.org/10.1016/S0092-8674(00)81959-5
Darnell JE (2005). Validating Stat3 in cancer therapy. Nat. Med. 11: 595-596.
http://dx.doi.org/10.1038/nm0605-595
PMid:15937466
Dauer DJ, Ferraro B, Song L, Yu B, et al. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408.
http://dx.doi.org/10.1038/sj.onc.1208469
PMid:15735721
Ferguson LR, Han DY, Fraser AG, Huebner C, et al. (2010). Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn’s disease in a New Zealand population. Mutat. Res. 690: 108-115.
http://dx.doi.org/10.1016/j.mrfmmm.2010.01.017
PMid:20109474
Fletcher S, Drewry JA, Shahani VM, Page BD, et al. (2009). Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein. Biochem. Cell Biol. 87: 825-833.
http://dx.doi.org/10.1139/O09-044
PMid:19935868
Grivennikov SI and Karin M (2010). Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21: 11-19.
http://dx.doi.org/10.1016/j.cytogfr.2009.11.005
Horinaga M, Okita H, Nakashima J, Kanao K, et al. (2005). Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology 66: 671-675.
http://dx.doi.org/10.1016/j.urology.2005.03.066
PMid:16140113
Hsieh FC, Cheng G and Lin J (2005). Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem. Biophys. Res. Commun. 335: 292-299.
http://dx.doi.org/10.1016/j.bbrc.2005.07.075
PMid:16081048
Hsu HS, Huang PI, Chang YL, Tzao C, et al. (2011). Cucurbitacin i inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 117: 2970-2985.
http://dx.doi.org/10.1002/cncr.25869
PMid:21225866
Ito N, Eto M, Nakamura E, Takahashi A, et al. (2007). STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 25: 2785-2791.
http://dx.doi.org/10.1200/JCO.2006.09.8897
PMid:17602083
Jing N, Zhu Q, Yuan P, Li Y, et al. (2006). Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther. 5: 279-286.
http://dx.doi.org/10.1158/1535-7163.MCT-05-0302
PMid:16505101
Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
http://dx.doi.org/10.1038/nature04870
PMid:16724054
Kreil S, Waghorn K, Ernst T, Chase A, et al. (2010). A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha. Haematologica 95: 148-152.
http://dx.doi.org/10.3324/haematol.2009.011510
PMid:20065083 PMCid:2805737
Lai SY and Johnson FM (2010). Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist. Updat. 13: 67-78.
http://dx.doi.org/10.1016/j.drup.2010.04.001
PMid:20471303
Lin Q, Lai R, Chirieac LR, Li C, et al. (2005). Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167: 969-980.
http://dx.doi.org/10.1016/S0002-9440(10)61187-X
Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108.
http://dx.doi.org/10.3322/canjclin.55.2.74
Sansone P, Storci G, Tavolari S, Guarnieri T, et al. (2007). IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117: 3988-4002.
http://dx.doi.org/10.1172/JCI32533
PMid:18060036 PMCid:2096439
Scagliotti GV, Longo M and Novello S (2009). Nonsmall cell lung cancer in never smokers. Curr. Opin. Oncol. 21: 99-104.
http://dx.doi.org/10.1097/CCO.0b013e328321049e
PMid:19532009
Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876.
http://dx.doi.org/10.1038/sj.onc.1205832
PMid:12362269
Siddiquee K, Zhang S, Guida WC, Blaskovich MA, et al. (2007a). Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc. Natl. Acad. Sci. U. S. A. 104: 7391-7396.
http://dx.doi.org/10.1073/pnas.0609757104
PMid:17463090 PMCid:1863497
Siddiquee KA, Gunning PT, Glenn M, Katt WP, et al. (2007b). An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem. Biol. 2: 787-798.
http://dx.doi.org/10.1021/cb7001973
PMid:18154266
Stephens M, Smith NJ and Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978-989.
http://dx.doi.org/10.1086/319501
PMid:11254454
Turkson J (2004). STAT proteins as novel targets for cancer drug discovery. Expert. Opin. Ther. Targets. 8: 409-422.
http://dx.doi.org/10.1517/14728222.8.5.409
PMid:15469392
Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, et al. (2007). Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. Endocr. Relat. Cancer 14: 267-277.
http://dx.doi.org/10.1677/ERC-06-0077
PMid:17639043
Weerasinghe P, Garcia GE, Zhu Q, Yuan P, et al. (2007). Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int. J. Oncol. 31: 129-136.
PMid:17549413
Yang L, Parkin DM, Li LD, Chen YD, et al. (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 90: 2157-2166.
PMid:15150609 PMCid:2409509
Yin W, Cheepala S, Roberts JN, Syson-Chan K, et al. (2006). Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol. Cancer 5: 15.
http://dx.doi.org/10.1186/1476-4598-5-15
PMid:16603078 PMCid:1502137
Yin ZJ, Jin FG, Liu TG, Fu EQ, et al. (2010). Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells. J. Surg. Res. Doi: 10.1016/j.jss.2010.03.053.
http://dx.doi.org/10.1016/j.jss.2010.03.053
PMid:20605584
Yu H and Jove R (2004). The STATs of cancer - new molecular targets come of age. Nat. Rev. Cancer 4: 97-105.
http://dx.doi.org/10.1038/nrc1275
PMid:14964307
Yu H, Pardoll D and Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9: 798-809.
http://dx.doi.org/10.1038/nrc2734
PMid:19851315